Molecular Nutrition and Food Research
Molecular Nutrition and Food Research
5 years ago

Pru p 3-Epitope-based sublingual immunotherapy in a murine model for the treatment of peach allergy

Pru p 3-Epitope-based sublingual immunotherapy in a murine model for the treatment of peach allergy
Maria J. Torres, Araceli Diaz-Perales, Javier Rojo, Nuria Cubells-Baeza, Francisca Gomez, Cristobalina Mayorga, Ainhoa Mascaraque, Maria J. Rodriguez, James R. Perkins, Javier Ramos-Soriano, David Andreu, Maria Garrido-Arandia
Scope Food-specific immunotherapy (SIT) is a promising treatment for lipid transfer protein (LTP)-syndrome. We propose a novel sublingual-SIT (SLIT) that combines a Pru p 3 T-cell peptide and an oligodeoxyribonucleotide (ODN) with CpG motifs (ODN-CpG) as adjuvants to induce a specific Th1/Treg response. Methods and results LTP-peach allergic mice were treated sublingually with a combination of a CpG sequence and mono- or tetravalent systems including a Pru p 3 peptide, D1(Prup3) or D4(Prup3). Mice were challenged intraperitoneally with Pru p 3 one or three weeks after SLIT and tolerance was assessed. Mice treated with D1(Prup3)+CpG were protected from anaphylaxis after Pru p 3 challenge. They showed no change in body temperature, lower levels of Pru p 3-specific IgE and IgG1 antibodies and higher levels of sIgG2a compared to the untreated group. They had fewer IgE and IgG1 secreting cells and more sIgG2a secreting cells. Moreover, a significantly lower number of Pru p 3-specific CD4+T cells and a higher number of Treg cells were found, alongside a Th1 cytokine pattern. These changes were maintained for three weeks after stopping treatment. Conclusion D1Prup3+CpG represents a promising SIT for food allergy. It is easily synthesized and induces protection from anaphylaxis to Pru p 3 that is maintained for at least three weeks. In this study, LTP-peach anaphylactic mice are treated sublingually with a combination of a CpG sequence and mono- or tetravalent systems including a Pru p 3 peptide. It is found that the monomeric compound administered sublingually represents a promising specific immunotherapy for food allergy since it is easily synthesized, safe, and induces a persistent protection from anaphylaxis to Pru p 3.

Publisher URL: http://onlinelibrary.wiley.com/resolve/doi

DOI: 10.1002/mnfr.201700110

You might also like
Discover & Discuss Important Research

Keeping up-to-date with research can feel impossible, with papers being published faster than you'll ever be able to read them. That's where Researcher comes in: we're simplifying discovery and making important discussions happen. With over 19,000 sources, including peer-reviewed journals, preprints, blogs, universities, podcasts and Live events across 10 research areas, you'll never miss what's important to you. It's like social media, but better. Oh, and we should mention - it's free.

  • Download from Google Play
  • Download from App Store
  • Download from AppInChina

Researcher displays publicly available abstracts and doesn’t host any full article content. If the content is open access, we will direct clicks from the abstracts to the publisher website and display the PDF copy on our platform. Clicks to view the full text will be directed to the publisher website, where only users with subscriptions or access through their institution are able to view the full article.